116 related articles for article (PubMed ID: 37897709)
1. A phase 1 trial of 8-chloro-adenosine in relapsed/refractory acute myeloid leukemia: An evaluation of safety and pharmacokinetics.
Pullarkat V; Chen LS; Palmer J; Zhang J; Synold TW; Buettner R; Truong Nguyen LX; Marcucci G; Tsai NC; Wang Y; O'Hearn J; Gandhi V; Rosen ST
Cancer; 2024 Mar; 130(5):727-739. PubMed ID: 37897709
[TBL] [Abstract][Full Text] [Related]
2. Targeting the metabolic vulnerability of acute myeloid leukemia blasts with a combination of venetoclax and 8-chloro-adenosine.
Buettner R; Nguyen LXT; Morales C; Chen MH; Wu X; Chen LS; Hoang DH; Hernandez Vargas S; Pullarkat V; Gandhi V; Marcucci G; Rosen ST
J Hematol Oncol; 2021 Apr; 14(1):70. PubMed ID: 33902674
[TBL] [Abstract][Full Text] [Related]
3. Plasma and cellular pharmacology of 8-chloro-adenosine in mice and rats.
Gandhi V; Chen W; Ayres M; Rhie JK; Madden TL; Newman RA
Cancer Chemother Pharmacol; 2002 Aug; 50(2):85-94. PubMed ID: 12172971
[TBL] [Abstract][Full Text] [Related]
4. 8-chloro-cAMP and 8-chloro-adenosine act by the same mechanism in multiple myeloma cells.
Gandhi V; Ayres M; Halgren RG; Krett NL; Newman RA; Rosen ST
Cancer Res; 2001 Jul; 61(14):5474-9. PubMed ID: 11454694
[TBL] [Abstract][Full Text] [Related]
5. Intracellular succinylation of 8-chloroadenosine and its effect on fumarate levels.
Dennison JB; Ayres ML; Kaluarachchi K; Plunkett W; Gandhi V
J Biol Chem; 2010 Mar; 285(11):8022-30. PubMed ID: 20064937
[TBL] [Abstract][Full Text] [Related]
6. A phase I clinical trial of 2-chlorodeoxyadenosine in pediatric patients with acute leukemia.
Santana VM; Mirro J; Harwood FC; Cherrie J; Schell M; Kalwinsky D; Blakley RL
J Clin Oncol; 1991 Mar; 9(3):416-22. PubMed ID: 1671875
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of topoisomerase II by 8-chloro-adenosine triphosphate induces DNA double-stranded breaks in 8-chloro-adenosine-exposed human myelocytic leukemia K562 cells.
Yang SY; Jia XZ; Feng LY; Li SY; An GS; Ni JH; Jia HT
Biochem Pharmacol; 2009 Feb; 77(3):433-43. PubMed ID: 19014910
[TBL] [Abstract][Full Text] [Related]
8. Synergy of Venetoclax and 8-Chloro-Adenosine in AML: The Interplay of rRNA Inhibition and Fatty Acid Metabolism.
Hoang DH; Morales C; Rodriguez IR; Valerio M; Guo J; Chen MH; Wu X; Horne D; Gandhi V; Chen LS; Zhang B; Pullarkat V; Rosen ST; Marcucci G; Buettner R; Nguyen LXT
Cancers (Basel); 2022 Mar; 14(6):. PubMed ID: 35326597
[TBL] [Abstract][Full Text] [Related]
9. 8-chloro-adenosine activity in FLT3-ITD acute myeloid leukemia.
Buettner R; Nguyen LXT; Kumar B; Morales C; Liu C; Chen LS; Pemovska T; Synold TW; Palmer J; Thompson R; Li L; Hoang DH; Zhang B; Ghoda L; Kowolik C; Kontro M; Leitch C; Wennerberg K; Yu X; Chen CC; Horne D; Gandhi V; Pullarkat V; Marcucci G; Rosen ST
J Cell Physiol; 2019 Sep; 234(9):16295-16303. PubMed ID: 30770553
[TBL] [Abstract][Full Text] [Related]
10. ATP directed agent, 8-chloro-adenosine, induces AMP activated protein kinase activity, leading to autophagic cell death in breast cancer cells.
Stellrecht CM; Vangapandu HV; Le XF; Mao W; Shentu S
J Hematol Oncol; 2014 Mar; 7():23. PubMed ID: 24628795
[TBL] [Abstract][Full Text] [Related]
11. 2-Chlorodeoxyadenosine produces a high rate of complete hematologic remission in relapsed acute myeloid leukemia.
Santana VM; Mirro J; Kearns C; Schell MJ; Crom W; Blakley RL
J Clin Oncol; 1992 Mar; 10(3):364-70. PubMed ID: 1346800
[TBL] [Abstract][Full Text] [Related]
12. E2F1 enhances 8-chloro-adenosine-induced G2/M arrest and apoptosis in A549 and H1299 lung cancer cells.
Duan HY; Cao JX; Qi JJ; Wu GS; Li SY; An GS; Jia HT; Cai WW; Ni JH
Biochemistry (Mosc); 2012 Mar; 77(3):261-9. PubMed ID: 22803943
[TBL] [Abstract][Full Text] [Related]
13. First-in-Human Phase I Study of Iadademstat (ORY-1001): A First-in-Class Lysine-Specific Histone Demethylase 1A Inhibitor, in Relapsed or Refractory Acute Myeloid Leukemia.
Salamero O; Montesinos P; Willekens C; Pérez-Simón JA; Pigneux A; Récher C; Popat R; Carpio C; Molinero C; Mascaró C; Vila J; Arévalo MI; Maes T; Buesa C; Bosch F; Somervaille TCP
J Clin Oncol; 2020 Dec; 38(36):4260-4273. PubMed ID: 33052756
[TBL] [Abstract][Full Text] [Related]
14. Preclinical activity of 8-chloroadenosine with mantle cell lymphoma: roles of energy depletion and inhibition of DNA and RNA synthesis.
Dennison JB; Balakrishnan K; Gandhi V
Br J Haematol; 2009 Nov; 147(3):297-307. PubMed ID: 19709085
[TBL] [Abstract][Full Text] [Related]
15. 8-Chloro-Adenosine Inhibits Proliferation of MDA-MB-231 and SK-BR-3 Breast Cancer Cells by Regulating ADAR1/p53 Signaling Pathway.
Ding HY; Yang WY; Zhang LH; Li L; Xie F; Li HY; Chen XY; Tu Z; Li Y; Chen Y; Yang SY
Cell Transplant; 2020; 29():963689720958656. PubMed ID: 32907379
[TBL] [Abstract][Full Text] [Related]
16. [8-Chloro-adenosine increases the activity of transcription factor CREB by modification of phosphorylation].
Chang XY; Fang JC; Wang NQ; Liu T; Su H
Ai Zheng; 2003 Apr; 22(4):350-3. PubMed ID: 12703986
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of CHK1 kinase by Gö6976 converts 8-chloro-adenosine-induced G2/M arrest into S arrest in human myelocytic leukemia K562 cells.
Jia XZ; Yang SY; Zhou J; Li SY; Ni JH; An GS; Jia HT
Biochem Pharmacol; 2009 Mar; 77(5):770-80. PubMed ID: 19059218
[TBL] [Abstract][Full Text] [Related]
18. A phase IV study evaluating QT interval, pharmacokinetics, and safety following fractionated dosing of gemtuzumab ozogamicin in patients with relapsed/refractory CD33-positive acute myeloid leukemia.
Montesinos P; Kota V; Brandwein J; Bousset P; Benner RJ; Vandendries E; Chen Y; McMullin MF
Cancer Chemother Pharmacol; 2023 May; 91(5):441-446. PubMed ID: 36892676
[TBL] [Abstract][Full Text] [Related]
19. Twice-daily fludarabine and cytarabine combination with or without gentuzumab ozogamicin is effective in patients with relapsed/refractory acute myeloid leukemia, high-risk myelodysplastic syndrome, and blast- phase chronic myeloid leukemia.
Jabbour E; Garcia-Manero G; Cortes J; Ravandi F; Plunkett W; Gandhi V; Faderl S; O'Brien S; Borthakur G; Kadia T; Burger J; Konopleva M; Brandt M; Huang X; Kantarjian H
Clin Lymphoma Myeloma Leuk; 2012 Aug; 12(4):244-51. PubMed ID: 22534616
[TBL] [Abstract][Full Text] [Related]
20. [Mechanisms of sensitization by 8-chloro-adenosine of human tumor cells to TRAIL-induced apoptosis].
Wang MJ; Liu YX; Zhang JC; Liu SL; Zheng DX
Zhonghua Zhong Liu Za Zhi; 2005 Oct; 27(10):586-90. PubMed ID: 16438865
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
